High efficacy reported for Sputnik V COVID-19 vaccine
(HealthDay)—A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), has 91.6 percent efficacy against COVID-19, according to a study published online Feb. 2 in The Lancet.
Read The Rest
at : https://medicalxpress.com/rss-feed
Major medical groups urge Americans to get COVID vaccine
Study shows young COVID survivors can get reinfected
COVID-19 health threat increases psychological distress...
No French Covid lockdown for now: PM
Surviving COVID-19 survivor's guilt
Dutch latest to limit AstraZeneca vaccine to under-65s
Dialysis patients have four-fold greater risk of dying...
COVID-19 vaccine safe and effective in animal models
Study shows flu vaccine lessens COVID-19 symptoms in...
Mast cells: Sentinels and high-speed messengers of the...
All Rights Reserved